Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol

被引：0
|
作者：
Matthias Uhl
Lutz Edler
Alexandra D Jensen
Gregor Habl
Jan Oelmann
Falk Röder
Oliver Jäckel
Jürgen Debus
Klaus Herfarth
机构：
[1] University of Heidelberg,Department of Radiation Oncology
[2] Heidelberg Ion Therapy Center (HIT),undefined
[3] German Cancer Research Center (dkfz),undefined
来源：
Radiation Oncology | / 9卷
关键词：
Sacral chordoma; Chordoma; Carbon ion therapy; Proton therapy; Irradiation; Randomized trial; Hypofractionation; Heavy ion therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases
    Kim, Kangpyo
    Yu, Jeong Il
    Park, Hee Chul
    Yoo, Gyu Sang
    Lim, Do Hoon
    Noh, Jae Myoung
    Jeong, Woo Kyoung
    RADIOTHERAPY AND ONCOLOGY, 2022, 176 : 9 - 16
  • [22] A protocol for a randomized trial evaluating the role of carbon-ion radiation therapy plus camrelizumab for patients with locoregionally recurrent nasopharyngeal carcinoma
    Hu, Jiyi
    Huang, Qingting
    Hu, Weixu
    Gao, Jing
    Yang, Jing
    Zhang, Haojiong
    Lu, Jiade Jay
    Kong, Lin
    CANCER MEDICINE, 2024, 13 (03):
  • [23] Hypofractionated Intensity Modulated Radiation Therapy Altered Patterns of Failure in Patients With Glioblastoma Multiforme Treated on a Phase II Trial
    Reddy, K.
    Damek, D.
    Gaspar, L. E.
    Ney, D.
    Kavanagh, B. D.
    Waziri, A.
    Lillehei, K.
    Stuhr, K.
    Chen, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S268 - S268
  • [24] Post-mastectomy hypofractionated versus conventionally fractionated radiation therapy for patients receiving immediate breast reconstruction: Subgroup analysis of a phase III randomized trial
    Zhang, Xiaomeng
    Wang, Xiaofang
    Chu, Yajuan
    Zhang, Li
    Meng, Jin
    Shi, Wei
    Chen, Xingxing
    Yang, Zhaozhi
    Mei, Xin
    Yu, Xiaoli
    Mo, Miao
    Zhang, Zhen
    Liu, Guangyu
    Wu, Jiong
    Shao, Zhimin
    Guo, Xiaomao
    Ma, Jinli
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2025, 50
  • [25] Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial
    Khan, Atif J.
    Poppe, Matthew M.
    Goyal, Sharad
    Kokeny, Kristine E.
    Kearney, Thomas
    Kirstein, Laurie
    Toppmeyer, Deborah
    Moore, Dirk F.
    Chen, Chunxia
    Gaffney, David K.
    Haffty, Bruce G.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (18) : 2037 - +
  • [26] Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer
    Lin, Steven H.
    Hobbs, Brian P.
    Verma, Vivek
    Tidwell, Rebecca S.
    Smith, Grace L.
    Lei, Xiudong
    Corsini, Erin M.
    Mok, Isabel
    Wei, Xiong
    Yao, Luyang
    Wang, Xin
    Komaki, Ritsuko U.
    Chang, Joe Y.
    Chun, Stephen G.
    Jeter, Melenda D.
    Swisher, Stephen G.
    Ajani, Jaffer A.
    Blum-Murphy, Mariela
    Vaporciyan, Ara A.
    Mehran, Reza J.
    Koong, Albert C.
    Gandhi, Saumil J.
    Hofstetter, Wayne L.
    Hong, Theodore S.
    Delaney, Thomas F.
    Liao, Zhongxing
    Mohan, Radhe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (14) : 1569 - +
  • [27] Hypofractionated Proton Therapy in Early Prostate Cancer: Results of a Phase I/II Trial at Loma Linda University
    Slater, Jason M.
    Slater, Jerry D.
    Kang, Joseph, I
    Namihas, Ivan C.
    Jabola, B. Rodney
    Brown, Kelcie
    Grove, Roger
    Watt, Cherie
    Bush, David A.
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2019, 6 (01): : 1 - 9
  • [28] Phase II Clinical Trial of Hypofractionated Image-Guided Proton Therapy with 12 Fractions for Prostate Cancer
    Iwata, H.
    Oguri, M.
    Hattori, Y.
    Nakajima, K.
    Tsuzuki, Y.
    Hayashi, K.
    Toshito, T.
    Umemoto, Y.
    Ogino, H.
    Hiwatashi, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E395 - E396
  • [29] Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma
    Ney, Douglas E.
    Carlson, Julie A.
    Damek, Denise M.
    Gaspar, Laurie E.
    Kavanagh, Brian D.
    Kleinschmidt-DeMasters, B. K.
    Waziri, Allen E.
    Lillehei, Kevin O.
    Reddy, Krishna
    Chen, Changhu
    JOURNAL OF NEURO-ONCOLOGY, 2015, 122 (01) : 135 - 143
  • [30] Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma
    Douglas E. Ney
    Julie A. Carlson
    Denise M. Damek
    Laurie E. Gaspar
    Brian D. Kavanagh
    B. K. Kleinschmidt-DeMasters
    Allen E. Waziri
    Kevin O. Lillehei
    Krishna Reddy
    Changhu Chen
    Journal of Neuro-Oncology, 2015, 122 : 135 - 143
12345